AdvanSix Q4 sales rise

AdvanSix

20/02/2026 11:40

Overview

Integrated chemistry firm's Q4 revenue rose 9% yr/yr, driven by higher sales volume

Adjusted EPS for Q4 was $0.03, down from previous year

Company completed planned plant turnarounds, focusing on cost savings and cash flow

Outlook

AdvanSix expects 2026 capital expenditures of $75 to $95 mln

Company anticipates cash flow benefits from 45Q carbon capture tax credits in 2026

AdvanSix sees continued strength in Plant Nutrients amid higher sulfur input  costs

Result Drivers

SALES VOLUME INCREASE - Q4 sales volume rose 11% due to prior year impact of extended plant turnaround

PLANT TURNAROUNDS - Successful completion of planned plant turnarounds improved operational efficiency

RAW MATERIAL COSTS - Decrease in benzene and propylene costs impacted raw material pass-through pricing

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Sales
Beat
$359.95 mln
$340.75 mln (2 Analysts)
Q4 Adjusted EPS
Beat
$0.03
-$0.06 (2 Analysts)

Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the specialty chemicals peer group is "buy"

Wall Street's median 12-month price target for AdvanSix Inc is $21.00, about 16.7% above its February 19 closing price of $18.00

The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 5 three months ago

Press Release: ID:nBw8pqhHxa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)